To what extent do pharmaceutical companies comply with human rights during the Covid-19 pandemic? Do they serve the global public interest and the right to access to life-saving health products, or can and must they do better for the common good?
The Pharmaceutical Accountability Foundation provides crystal-clear and confronting answers with the Fair Pharma Scorecard, a ranking of 26 pharmaceutical companies based on their compliance with relevant human rights principles. It shows how they perform when it comes to human rights commitments, transparency, international cooperation, and equality, non-discrimination and equity.
We launched the Fair Pharma Scorecard website on 28 June: fairpharmascorecard.org
Programme of the event:
In this online event on 30 June, we present the results of the scorecard. Which companies score worst, and which companies score best on human rights compliance? Which practices are guiding lights for pandemic preparedness and response, and which practices must become ancient history?
We then discuss the scorecard with the pharmaceutical companies that we have assessed. Representatives of two of the top-scoring companies, Dr Maria Elena Bottazzi from Texas Children’s Hospital and Dr Vicente Vérez Bencomo from the Cuban Finlay Institute of Vaccines, will offer their perspectives on the academic value of the Fair Pharma Scorecard and reflections on their own scores.
This event is organised by the Pharmaceutical Accountability Foundation with the support of Wemos.